Anti Mullerian Hormone

I am a returning customer
I want this for my family

Product Description

AMH Hormone is present in both females and males and levels in the body differ according to age and gender. In females, the amount of Anti Mullerian Hormone present indicates follicular growth. Anti Mullerian Hormone is extremely important for women during childbearing years.

AMH along with FSH (Follicular Stimulating Hormone) and LH (Luteinizing Hormone) has a balancing role in the monthly process of egg maturation and release. AMH test is also more commonly called as the Ovarian Reserve Marker because it gives an indication of a woman’s remaining egg maturation potential the likelihood of conceiving. The levels of Anti Mullerian Hormone in the blood drop significantly at the onset of menospause and virtually absent after menopause. Hence the AMH test is also a predictor for onset of Menopause.

AMH test is also more commonly used in the diagnosis of PCOS (Polycystic Ovarian Syndrome) PCOS is marked by excess follicles which in turn produce abnormally high amounts of AMH. This is also observed in case of a ovarian tumor. An Anti Mullerian Hormone test may be ordered when evaluating ovarian function, fertility issues, especially when considering assisted reproduction procedures such as IVF.

AMH test is not just an ovarian reserve marker but a diagnostic and prognostic marker in Non IVF setting and a predictive marker in IVF setting.

FeatureValue
SpecimenSerum (Blood)
Related TestsFSH, LH, Inhibin B, Estradiol, Testosterone, Progesterone
Schedule Visit
Opt for Metropolis, The Pathology Specialist
The Metropolis Edge

The Metropolis Edge

  • Report trusted by Doctors.
  • Global & National Quality Accreditations – CAP (USA) and NABL , Govt. of India.
  • Guaranteed error free diagnosis.
  • Bar Coded and automated process. No room for manual errors.
  • Specific normal range for Indian population built from 33 years of experience.
  • Sample collection from home/office.
Metropolis: Experience + Expertise

Metropolis: Experience + Expertise

Over the past 3 decades we have earned the respect of doctors and patients. Today we conduct over 30 million tests annually with accuracy each year. Our repertoire extends over 4500 tests and over 100 different technologies. Our customer care is available round the clock for any queries that you may have.

Reach out to our Counsellors
Comprehensive Analysis Of Your Health
Save tax on the Preventive health check-ups up to Rs. 5000, under section 80D of Income Tax Act, 1961
We are Metropolis - Your Pathology Specialist

Metropolis is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). With operations across India, Africa, South Asia and Middle East.

Our globally accredited clinical laboratories deliver accurate and timely test results. We offer a comprehensive range of clinical laboratory tests and profiles which are used in prediction, early detection, diagnostic screening, confirmation and monitoring of diseases.

 

  • Delivering diagnostic services since 1980
  • Network of 100+ clinical labs & 1100+ patient touch points
  • Qualified team of phlebotomists for Home collection services

 

  • Certified NABL and CAP accredited labs
  • Wide range of 4000+ tests & profiles
  • Convenience of home collection service

 

Metropolis Healthcare Limited is proposing subject to applicable statutory or regulatory requirements, receipt of requisite approvals, market conditions and other considerations to undertake an initial public offering of its equity shares and has filed a draft red herring prospectus dated September 27, 2018 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of the SEBI at www.sebi.gov.in, BSE Limited at www.bseindia.com, National Stock Exchange of India Limited at www.nseindia.com and the websites of Book Running Lead Managers at www.jmfl.com, www.credit-suisse.com, www.investmentbank.kotak.com, www.hdfcbank.com and www.goldmansachs.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to same, please refer to the DRHP including the section “Risk Factors” of the DRHP. Potential investors should not rely on the DRHP filed with the SEBI for making any investment decision.

 

Scroll Up